Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin Effect on Glucagon in T1DM with Autonomic Neuropathy
NCT01452113Phase 2Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Oct 2010
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vildagliptin in type 1 diabetes mellitus (T1D), sponsored by Centre hospitalier universitaire de Toulouse. Started Oct 2010; status: completed.
02
Drugs
vildagliptin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01452113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01452113.